AstraZeneca Says Its COVID-19 Vaccine Produces Robust Immune Response In Elderly Patients
October 26, 2020 at 11:00 AM EDT
Days after US regulators gave the AstraZeneca - Oxford vaccine the green light to re-start its US-based trials, the FT is reporting new data that seems promising, even if it's still pretty preliminary.